Palbociclib,Sunitinib,Temsirolimus,Trastuzumab,Pertuzumab,Vemurafenib,Cobimetinib,Regorafenib,Olaparib,Pembrolizumab,Nivolumab,Ipilimumab,Abemaciclib,Talazoparib,Atezolizumab,Entrectinib,Larotrectinib,Tucatinib,Futibatinib
Pfizer,Roche,bayer,Astrazeneca,Merck,bms,eli lilly,Seagen,Otsuka
['brca', 'tapur', 'basket trial']
when we find it, however, we should act! timothy yap reviews evidence that gbrca1/2m demonstrate responses to parpi, even beyond brca1/2-associated cancers. eagerly await finalized results of #tapur and other basket trials! #hereditarycancer #germlinetesting #asco23 
Chief Fellow #HemOnc @univmiami @SylvesterCancer+@JacksonHealth
Former #MedEd Chief @gtown_medres
Tweets/likes ≠ medical advice | he/him | #LCSM |